Polymyalgia rheumatica

Patients are to follow up immediately with their rheumatologist or other provider upon developing any recurrent or new visual symptoms, other symptoms suggestive of GCA, worsening of their PMR symptoms, or signs of infections (i.e., fevers, chills, sweats, new cough, and shortness of breath). Patients receiving tocilizumab should seek help immediately if they develop signs and symptoms of liver injury.[56]Medicines and Healthcare products Regulatory Agency. Tocilizumab (RoActemra): rare risk of serious liver injury including cases requiring transplantation. Jul 2019 [internet publication]. https://www.gov.uk/drug-safety-update/tocilizumab-roactemra-rare-risk-of-serious-liver-injury-including-cases-requiring-transplantation

Instruct patients to take their corticosteroid medication daily as prescribed. Patients should be advised that signs of corticosteroid withdrawal (i.e., arthralgias, malaise, and fatigue) may occur with tapering, but these symptoms should resolve after a few days.